{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:12:44Z","timestamp":1782450764013,"version":"3.54.5"},"reference-count":29,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":764,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/all.12183","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T09:24:44Z","timestamp":1375089884000},"page":"994-1000","source":"Crossref","is-referenced-by-count":73,"title":["Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors"],"prefix":"10.1111","volume":"68","author":[{"given":"E.","family":"Gaffal","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Dermatology; Department of Dermatology and Allergy; University of Bonn; Bonn; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cron","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Dermatology; Department of Dermatology and Allergy; University of Bonn; Bonn; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Glodde","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Dermatology; Department of Dermatology and Allergy; University of Bonn; Bonn; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"T\u00fcting","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Dermatology; Department of Dermatology and Allergy; University of Bonn; Bonn; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,29]]},"reference":[{"key":"10.1111\/all.12183-BIB0001|all12183-cit-0001","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1398-9995.2011.02652.x","article-title":"Mechanisms of chemical-induced innate immunity in allergic contact dermatitis","volume":"66","author":"Martin","year":"2011","journal-title":"Allergy"},{"key":"10.1111\/all.12183-BIB0002|all12183-cit-0002","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nri3150","article-title":"Early immune events in the induction of allergic contact dermatitis","volume":"12","author":"Kaplan","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/all.12183-BIB0003|all12183-cit-0003","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","article-title":"Attenuation of allergic contact dermatitis through the endocannabinoid system","volume":"316","author":"Karsak","year":"2007","journal-title":"Science"},{"key":"10.1111\/all.12183-BIB0004|all12183-cit-0004","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1398-9995.2009.02254.x","article-title":"Protective role of palmitoylethanolamide in contact allergic dermatitis","volume":"65","author":"Petrosino","year":"2010","journal-title":"Allergy"},{"key":"10.1111\/all.12183-BIB0005|all12183-cit-0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/all.12183-BIB0006|all12183-cit-0006","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med Chem"},{"key":"10.1111\/all.12183-BIB0007|all12183-cit-0007","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1600-0625.2009.00923.x","article-title":"Cannabinoid system in the skin - a possible target for future therapies in dermatology","volume":"18","author":"Kupczyk","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1111\/all.12183-BIB0008|all12183-cit-0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/all.12183-BIB0009|all12183-cit-0009","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2006.03.021","article-title":"Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol","volume":"538","author":"Oka","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/all.12183-BIB0010|all12183-cit-0010","doi-asserted-by":"crossref","first-page":"33896","DOI":"10.1074\/jbc.M303994200","article-title":"The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase","volume":"278","author":"Maccarrone","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/all.12183-BIB0011|all12183-cit-0011","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/ACI.0b013e32833e08ae","article-title":"Keratinocytes in allergic skin diseases","volume":"10","author":"Albanesi","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/all.12183-BIB0012|all12183-cit-0012","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.imbio.2010.09.004","article-title":"Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1\/CB2 receptors","volume":"216","author":"Braun","year":"2011","journal-title":"Immunobiology"},{"key":"10.1111\/all.12183-BIB0013|all12183-cit-0013","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1155\/2001\/326867","article-title":"Cannabinoids and the immune system","volume":"6","author":"Klein","year":"2001","journal-title":"Pain Res Manag"},{"key":"10.1111\/all.12183-BIB0014|all12183-cit-0014","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/08923978509026487","article-title":"The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses","volume":"7","author":"Klein","year":"1985","journal-title":"J Immunopharmacol"},{"key":"10.1111\/all.12183-BIB0015|all12183-cit-0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1373.2000.22501.x","article-title":"The cannabinoid system and cytokine network","volume":"225","author":"Klein","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/all.12183-BIB0016|all12183-cit-0016","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.0.CO;2-W","article-title":"Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells","volume":"29","author":"Puffenbarger","year":"2000","journal-title":"Glia"},{"key":"10.1111\/all.12183-BIB0017|all12183-cit-0017","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bcp.2010.02.015","article-title":"Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin","volume":"79","author":"Leonti","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/all.12183-BIB0018|all12183-cit-0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","article-title":"Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis","volume":"45","author":"Wilkinson","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1111\/all.12183-BIB0019|all12183-cit-0019","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1022413901857","article-title":"Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes","volume":"22","author":"Bloom","year":"1997","journal-title":"Neurochem Res"},{"key":"10.1111\/all.12183-BIB0020|all12183-cit-0020","first-page":"1103","article-title":"Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1","volume":"286","author":"Zhu","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/all.12183-BIB0021|all12183-cit-0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-5793(95)00746-V","article-title":"Cannabinoids enhance human B-cell growth at low nanomolar concentrations","volume":"369","author":"Derocq","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1111\/all.12183-BIB0022|all12183-cit-0022","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/978-94-007-0265-3_44","article-title":"Roles of transient receptor potential proteins (TRPs) in epidermal keratinocytes","volume":"704","author":"Denda","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/all.12183-BIB0023|all12183-cit-0023","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature02282","article-title":"Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1","volume":"427","author":"Jordt","year":"2004","journal-title":"Nature"},{"key":"10.1111\/all.12183-BIB0024|all12183-cit-0024","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/jid.2009.58","article-title":"Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin","volume":"129","author":"Atoyan","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/all.12183-BIB0025|all12183-cit-0025","article-title":"The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas","volume":"10","author":"Perez-Gomez","year":"2012","journal-title":"Oncogene"},{"key":"10.1111\/all.12183-BIB0026|all12183-cit-0026","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1111\/all.12183-BIB0027|all12183-cit-0027","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/all.12183-BIB0028|all12183-cit-0028","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","article-title":"Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease","volume":"215","author":"O'Sullivan","year":"2010","journal-title":"Immunobiology"},{"key":"10.1111\/all.12183-BIB0029|all12183-cit-0029","first-page":"801","article-title":"Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus","volume":"57","author":"Stander","year":"2006","journal-title":"Hautarzt"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12183","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T02:13:29Z","timestamp":1625451209000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.12183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,29]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12183","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,29]]}}}